-
1
-
-
49449093566
-
Human papillomavirus genotype distribution in external acuminata condylomata: A large French national study (EDiTH IV)
-
EDiTH Study Group.
-
Aubin F, Prétet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D, EDiTH Study Group. 2008. Human papillomavirus genotype distribution in external acuminata condylomata: A large French national study (EDiTH IV). Clin Infect Dis 47: 610-615.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 610-615
-
-
Aubin, F.1
Prétet, J.L.2
Jacquard, A.C.3
Saunier, M.4
Carcopino, X.5
Jaroud, F.6
Pradat, P.7
Soubeyrand, B.8
Leocmach, Y.9
Mougin, C.10
Riethmuller, D.11
-
2
-
-
77950938389
-
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
-
Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
-
(2010)
Virology
, vol.401
, pp. 70-79
-
-
Bernard, H.U.1
Burk, R.D.2
Chen, Z.3
van Doorslaer, K.4
Hausen, H.5
de Villiers, E.M.6
-
3
-
-
33947586116
-
Developing an HPV vaccine to prevent cervical cancer and genital warts
-
Bryan JT. 2007. Developing an HPV vaccine to prevent cervical cancer and genital warts. Vaccine 25: 3001-3006.
-
(2007)
Vaccine
, vol.25
, pp. 3001-3006
-
-
Bryan, J.T.1
-
4
-
-
10744221855
-
Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix
-
Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A. 2003. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63: 7215-7220.
-
(2003)
Cancer Res
, vol.63
, pp. 7215-7220
-
-
Burk, R.D.1
Terai, M.2
Gravitt, P.E.3
Brinton, L.A.4
Kurman, R.J.5
Barnes, W.A.6
Greenberg, M.D.7
Hadjimichael, O.C.8
Fu, L.9
McGowan, L.10
Mortel, R.11
Schwartz, P.E.12
Hildesheim, A.13
-
5
-
-
17144446125
-
Intratype sequence variation among clinical isolates of the human papillomavirus type 6 L1 ORF: Clustering of mutations and identification of a frequent amino acid sequence variant
-
Caparrós-Wanderley W, Savage N, Hill-Perkins M, Layton G, Weber J, Davies DH. 1999. Intratype sequence variation among clinical isolates of the human papillomavirus type 6 L1 ORF: Clustering of mutations and identification of a frequent amino acid sequence variant. J Gen Virol 80: 1025-1033.
-
(1999)
J Gen Virol
, vol.80
, pp. 1025-1033
-
-
Caparrós-Wanderley, W.1
Savage, N.2
Hill-Perkins, M.3
Layton, G.4
Weber, J.5
Davies, D.H.6
-
6
-
-
0028122275
-
E5a gene of human papillomavirus type 11 is required for initiation but not for maintenance of transformation in NIH 3T3 cells
-
Chen SL, Tsao YP, Lee JW, Liu HS, Yang CM, Tsao LT. 1994. E5a gene of human papillomavirus type 11 is required for initiation but not for maintenance of transformation in NIH 3T3 cells. J Gen Virol 75: 1953-1960.
-
(1994)
J Gen Virol
, vol.75
, pp. 1953-1960
-
-
Chen, S.L.1
Tsao, Y.P.2
Lee, J.W.3
Liu, H.S.4
Yang, C.M.5
Tsao, L.T.6
-
7
-
-
0029940993
-
Mutational analysis of human papillomavirus type 11 E5a oncoprotein
-
Chen SL, Tsai TZ, Han CP, Tsao YP. 1996a. Mutational analysis of human papillomavirus type 11 E5a oncoprotein. J Virol 70: 3502-3508.
-
(1996)
J Virol
, vol.70
, pp. 3502-3508
-
-
Chen, S.L.1
Tsai, T.Z.2
Han, C.P.3
Tsao, Y.P.4
-
8
-
-
0029861947
-
E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element
-
Chen SL, Lin YK, Li LY, Tsao YP, Lo HY, Wang WB, Tsai TC. 1996b. E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element. J Virol 70: 8558-8563.
-
(1996)
J Virol
, vol.70
, pp. 8558-8563
-
-
Chen, S.L.1
Lin, Y.K.2
Li, L.Y.3
Tsao, Y.P.4
Lo, H.Y.5
Wang, W.B.6
Tsai, T.C.7
-
9
-
-
18544380961
-
Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer
-
Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. 2005. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14: 1157-1164.
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 1157-1164
-
-
Clifford, G.M.1
Rana, R.K.2
Franceschi, S.3
Smith, J.S.4
Gough, G.5
Pimenta, J.M.6
-
10
-
-
0036569121
-
Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant
-
Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM. 2002. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 185: 1229-1237.
-
(2002)
J Infect Dis
, vol.185
, pp. 1229-1237
-
-
Da Costa, M.M.1
Hogeboom, C.J.2
Holly, E.A.3
Palefsky, J.M.4
-
11
-
-
0022569899
-
The nucleotide sequence and genome organization of human papilloma virus type 11
-
Dartmann K, Schwarz E, Gissmann L, zur Hausen H. 1986. The nucleotide sequence and genome organization of human papilloma virus type 11. Virology 151: 124-130.
-
(1986)
Virology
, vol.151
, pp. 124-130
-
-
Dartmann, K.1
Schwarz, E.2
Gissmann, L.3
zur Hausen, H.4
-
12
-
-
34250736244
-
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis
-
de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7: 453-459.
-
(2007)
Lancet Infect Dis
, vol.7
, pp. 453-459
-
-
de Sanjosé, S.1
Diaz, M.2
Castellsagué, X.3
Clifford, G.4
Bruni, L.5
Muñoz, N.6
Bosch, F.X.7
-
13
-
-
2942567871
-
Classification of papillomaviruses
-
de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324: 17-27.
-
(2004)
Virology
, vol.324
, pp. 17-27
-
-
de Villiers, E.M.1
Fauquet, C.2
Broker, T.R.3
Bernard, H.U.4
zur Hausen, H.5
-
14
-
-
33646675570
-
Molecular biology of human papillomavirus infection and cervical cancer
-
Doorbar J. 2006. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110: 525-541.
-
(2006)
Clin Sci (Lond)
, vol.110
, pp. 525-541
-
-
Doorbar, J.1
-
15
-
-
0028075834
-
Laryngeal papillomatosis: Molecular, histopathological, and clinical evaluation
-
Gale N, Poljak M, Kambič V, Ferluga D, Fischinger J. 1994. Laryngeal papillomatosis: Molecular, histopathological, and clinical evaluation. Virchows Arch 425: 291-295.
-
(1994)
Virchows Arch
, vol.425
, pp. 291-295
-
-
Gale, N.1
Poljak, M.2
Kambič, V.3
Ferluga, D.4
Fischinger, J.5
-
16
-
-
34248365967
-
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
-
Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators.
-
Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA, Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. 2007. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356: 1928-1943.
-
(2007)
N Engl J Med
, vol.356
, pp. 1928-1943
-
-
Garland, S.M.1
Hernandez-Avila, M.2
Wheeler, C.M.3
Perez, G.4
Harper, D.M.5
Leodolter, S.6
Tang, G.W.7
Ferris, D.G.8
Steben, M.9
Bryan, J.10
Taddeo, F.J.11
Railkar, R.12
Esser, M.T.13
Sings, H.L.14
Nelson, M.15
Boslego, J.16
Sattler, C.17
Barr, E.18
Koutsky, L.A.19
-
17
-
-
0019948750
-
Molecular cloning and characterization of human papilloma virus DNA derived from laryngeal papilloma
-
Gissmann L, Diehl V, Schultz-Coulon HJ, zur Hausen H. 1982. Molecular cloning and characterization of human papilloma virus DNA derived from laryngeal papilloma. J Virol 44: 393-400.
-
(1982)
J Virol
, vol.44
, pp. 393-400
-
-
Gissmann, L.1
Diehl, V.2
Schultz-Coulon, H.J.3
zur Hausen, H.4
-
18
-
-
33646227439
-
Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant
-
Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I. 2006. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 15: 820-822.
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, pp. 820-822
-
-
Grodzki, M.1
Besson, G.2
Clavel, C.3
Arslan, A.4
Franceschi, S.5
Birembaut, P.6
Tommasino, M.7
Zehbe, I.8
-
19
-
-
0029033863
-
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world
-
Heinzel PA, Chan SY, Ho L, O'Connor M, Balaram P, Campo MS, Fujinaga K, Kiviat N, Kuypers J, Pfister H, Steinberg BM, Tay SK, Villa LL, Bernard HU. 1995. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol 33: 1746-1754.
-
(1995)
J Clin Microbiol
, vol.33
, pp. 1746-1754
-
-
Heinzel, P.A.1
Chan, S.Y.2
Ho, L.3
O'Connor, M.4
Balaram, P.5
Campo, M.S.6
Fujinaga, K.7
Kiviat, N.8
Kuypers, J.9
Pfister, H.10
Steinberg, B.M.11
Tay, S.K.12
Villa, L.L.13
Bernard, H.U.14
-
20
-
-
68549095958
-
Prevaccination genomic diversity of human papillomavirus genotype 6 (HPV 6)
-
Kocjan BJ, Poljak M, Cimerman M, Gale N, Potočnik M, Bogovac Ž, Seme K. 2009. Prevaccination genomic diversity of human papillomavirus genotype 6 (HPV 6). Virology 391: 274-283.
-
(2009)
Virology
, vol.391
, pp. 274-283
-
-
Kocjan, B.J.1
Poljak, M.2
Cimerman, M.3
Gale, N.4
Potočnik, M.5
Bogovac, Z.6
Seme, K.7
-
21
-
-
51349169509
-
Koilocytosis: A cooperative interaction between the human papillomavirus E5 and E6 oncoproteins
-
Krawczyk E, Suprynowicz FA, Liu X, Dai Y, Hartmann DP, Hanover J, Schlegel R. 2008. Koilocytosis: A cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am J Pathol 173: 682-688.
-
(2008)
Am J Pathol
, vol.173
, pp. 682-688
-
-
Krawczyk, E.1
Suprynowicz, F.A.2
Liu, X.3
Dai, Y.4
Hartmann, D.P.5
Hanover, J.6
Schlegel, R.7
-
22
-
-
78650629202
-
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
-
DOI: 10.1002/ijc.25396. [Epub ahead of print].
-
Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. 2010. Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J cancer DOI: 10.1002/ijc.25396. [Epub ahead of print].
-
(2010)
Int J cancer
-
-
Li, N.1
Franceschi, S.2
Howell-Jones, R.3
Snijders, P.J.4
Clifford, G.M.5
-
23
-
-
0029941003
-
Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11
-
Ludmerer SW, Benincasa D, Mark GE, III. 1996. Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11. J Virol 70: 4791-4794.
-
(1996)
J Virol
, vol.70
, pp. 4791-4794
-
-
Ludmerer, S.W.1
Benincasa, D.2
Mark III, G.E.3
-
24
-
-
0030896195
-
A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope
-
Ludmerer SW, Benincasa D, Mark GE, III, Christensen ND. 1997. A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope. J Virol 71: 3834-3839.
-
(1997)
J Virol
, vol.71
, pp. 3834-3839
-
-
Ludmerer, S.W.1
Benincasa, D.2
Mark III, G.E.3
Christensen, N.D.4
-
25
-
-
0034688151
-
HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain
-
Ludmerer SW, McClements WL, Wang XM, Ling JC, Jansen KU, Christensen ND. 2000. HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain. Virology 266: 237-245.
-
(2000)
Virology
, vol.266
, pp. 237-245
-
-
Ludmerer, S.W.1
McClements, W.L.2
Wang, X.M.3
Ling, J.C.4
Jansen, K.U.5
Christensen, N.D.6
-
26
-
-
0026478851
-
Cellular transformation by a unique isolate of human papillomavirus type 11
-
Erratum in: 1997. Cancer Res 57:3867.
-
McGlennen RC, Ghai J, Ostrow RS, LaBresh K, Schneider JF, Faras AJ. 1992. Cellular transformation by a unique isolate of human papillomavirus type 11. Cancer Res 52: 5872-5878. Erratum in: 1997. Cancer Res 57:3867.
-
(1992)
Cancer Res
, vol.52
, pp. 5872-5878
-
-
McGlennen, R.C.1
Ghai, J.2
Ostrow, R.S.3
LaBresh, K.4
Schneider, J.F.5
Faras, A.J.6
-
27
-
-
0037421589
-
Epidemiologic classification of human papillomavirus types associated with cervical cancer
-
International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.
-
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
-
(2003)
N Engl J Med
, vol.348
, pp. 518-527
-
-
Muñoz, N.1
Bosch, F.X.2
de Sanjosé, S.3
Herrero, R.4
Castellsagué, X.5
Shah, K.V.6
Snijders, P.J.7
Meijer, C.J.8
-
28
-
-
3142661757
-
Against which papillomavirus types shall we vaccinate and screen? The international perspective
-
Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ. 2004. Against which papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111: 278-285.
-
(2004)
Int J Cancer
, vol.111
, pp. 278-285
-
-
Muñoz, N.1
Bosch, F.X.2
Castellsagué, X.3
Díaz, M.4
de Sanjose, S.5
Hammouda, D.6
Shah, K.V.7
Meijer, C.J.8
-
29
-
-
1242319382
-
Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11
-
Oh ST, Longworth MS, Laimins LA. 2004. Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol 78: 2620-2626.
-
(2004)
J Virol
, vol.78
, pp. 2620-2626
-
-
Oh, S.T.1
Longworth, M.S.2
Laimins, L.A.3
-
30
-
-
77949522195
-
Characterization of human papillomavirus type 11-specific immune responses in a preclinical model
-
Peng S, Best SR, Hung CF, Loyo M, Lyford-Pike S, Flint PW, Tunkel DE, Saunders JR, Wu TC, Pai SI. 2010. Characterization of human papillomavirus type 11-specific immune responses in a preclinical model. Laryngoscope 120: 504-510.
-
(2010)
Laryngoscope
, vol.120
, pp. 504-510
-
-
Peng, S.1
Best, S.R.2
Hung, C.F.3
Loyo, M.4
Lyford-Pike, S.5
Flint, P.W.6
Tunkel, D.E.7
Saunders, J.R.8
Wu, T.C.9
Pai, S.I.10
-
32
-
-
77951027069
-
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia
-
Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD. 2010. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70: 3159-3169.
-
(2010)
Cancer Res
, vol.70
, pp. 3159-3169
-
-
Schiffman, M.1
Rodriguez, A.C.2
Chen, Z.3
Wacholder, S.4
Herrero, R.5
Hildesheim, A.6
Desalle, R.7
Befano, B.8
Yu, K.9
Safaeian, M.10
Sherman, M.E.11
Morales, J.12
Guillen, D.13
Alfaro, M.14
Hutchinson, M.15
Solomon, D.16
Castle, P.E.17
Burk, R.D.18
-
33
-
-
33745069327
-
Epidemiological and functional implications of molecular variants of human papillomavirus
-
Sichero L, Villa LL. 2006. Epidemiological and functional implications of molecular variants of human papillomavirus. Braz J Med Biol Res 39: 707-717.
-
(2006)
Braz J Med Biol Res
, vol.39
, pp. 707-717
-
-
Sichero, L.1
Villa, L.L.2
-
34
-
-
33947121724
-
High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18
-
Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL. 2007. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120: 1763-1768.
-
(2007)
Int J Cancer
, vol.120
, pp. 1763-1768
-
-
Sichero, L.1
Ferreira, S.2
Trottier, H.3
Duarte-Franco, E.4
Ferenczy, A.5
Franco, E.L.6
Villa, L.L.7
-
35
-
-
34250818010
-
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
-
Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121: 621-632.
-
(2007)
Int J Cancer
, vol.121
, pp. 621-632
-
-
Smith, J.S.1
Lindsay, L.2
Hoots, B.3
Keys, J.4
Franceschi, S.5
Winer, R.6
Clifford, G.M.7
-
36
-
-
34547781750
-
MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0
-
Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
-
(2007)
Mol Biol Evol
, vol.24
, pp. 1596-1599
-
-
Tamura, K.1
Dudley, J.2
Nei, M.3
Kumar, S.4
-
37
-
-
0029839485
-
(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes
-
(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes. J Virol 70: 7535-7539.
-
(1996)
J Virol
, vol.70
, pp. 7535-7539
-
-
Tsao, Y.P.1
Li, L.Y.2
Tsai, T.C.3
Chen, S.L.4
-
38
-
-
62849098793
-
Detection of HPV types and neutralizing antibodies in Gansu province, China
-
Wu X, Zhang C, Feng S, Liu C, Li Y, Yang Y, Gao J, Li H, Meng S, Li L, Zhang Y, Hu X, Wu X, Lin L, Li X, Wang Y. 2009. Detection of HPV types and neutralizing antibodies in Gansu province, China. J Med Virol 81: 693-702.
-
(2009)
J Med Virol
, vol.81
, pp. 693-702
-
-
Wu, X.1
Zhang, C.2
Feng, S.3
Liu, C.4
Li, Y.5
Yang, Y.6
Gao, J.7
Li, H.8
Meng, S.9
Li, L.10
Zhang, Y.11
Hu, X.12
Wu, X.13
Lin, L.14
Li, X.15
Wang, Y.16
-
39
-
-
0029154680
-
Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection
-
Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA. 1995. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172: 747-755.
-
(1995)
J Infect Dis
, vol.172
, pp. 747-755
-
-
Xi, L.F.1
Demers, G.W.2
Koutsky, L.A.3
Kiviat, N.B.4
Kuypers, J.5
Watts, D.H.6
Holmes, K.K.7
Galloway, D.A.8
|